USRE46117E1 - Modulators of dopamine neurotransmission - Google Patents

Modulators of dopamine neurotransmission Download PDF

Info

Publication number
USRE46117E1
USRE46117E1 US14/693,783 US200014693783A USRE46117E US RE46117 E1 USRE46117 E1 US RE46117E1 US 200014693783 A US200014693783 A US 200014693783A US RE46117 E USRE46117 E US RE46117E
Authority
US
United States
Prior art keywords
patient
compound
treatment
administering
therapeutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US14/693,783
Inventor
Clas Sonesson
Bengt Andersson
Susanna Waters
Nicholas Waters
Joakim Tedroff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prilenia Neurotherapeutics Ltd
Original Assignee
Teva Pharmaceuticals International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SE9904724A priority Critical patent/SE9904724D0/en
Priority to SE9904724 priority
Application filed by Teva Pharmaceuticals International GmbH filed Critical Teva Pharmaceuticals International GmbH
Priority to US16817300A priority
Priority to PCT/SE2000/002674 priority patent/WO2001046145A1/en
Priority to US14/693,783 priority patent/USRE46117E1/en
Application granted granted Critical
Publication of USRE46117E1 publication Critical patent/USRE46117E1/en
Assigned to PRILENIA THERAPEUTICS DEVELOPMENT LTD. reassignment PRILENIA THERAPEUTICS DEVELOPMENT LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Assigned to PRILENIA NEUROTHERAPEUTICS LTD. reassignment PRILENIA NEUROTHERAPEUTICS LTD. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: PRILENIA THERAPEUTICS DEVELOPMENT LTD.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links